| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |